Immediate Impact
42 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Wei‐Ting Hsu being referenced
Overview of current systemic management of EGFR-mutant NSCLC
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Wei‐Ting Hsu | 29 | 28 | 23 | 206 | 170 | 14 | 412 | |
| Boda Wang | 5 | 27 | 2 | 66 | 161 | 11 | 375 | |
| Suqin Zheng | 4 | 107 | 2 | 125 | 85 | 13 | 385 | |
| Pablo Carretero | 13 | 42 | 4 | 106 | 45 | 21 | 413 | |
| Huijuan Dai | 3 | 122 | 4 | 57 | 93 | 26 | 490 | |
| Charles W. Axten | 2 | 12 | 150 | 266 | 39 | 13 | 403 | |
| Raúl Barrera Rodríguez | 10 | 33 | 36 | 165 | 119 | 27 | 420 | |
| Wan-Yi Kang | 24 | 148 | 26 | 243 | 100 | 19 | 502 | |
| Marco De Felice | 16 | 47 | 50 | 100 | 57 | 20 | 376 | |
| Yuqiao Chen | 6 | 115 | 8 | 170 | 99 | 29 | 427 | |
| Yongjie Zhang | 12 | 242 | 1 | 189 | 138 | 36 | 496 |
All Works
Login with ORCID to disown or claim papers
Loading papers...